Home Cart 0 Sign in  
X

[ CAS No. 21901-18-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 21901-18-8
Chemical Structure| 21901-18-8
Chemical Structure| 21901-18-8
Structure of 21901-18-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 21901-18-8 ]

Related Doc. of [ 21901-18-8 ]

Alternatived Products of [ 21901-18-8 ]

Product Details of [ 21901-18-8 ]

CAS No. :21901-18-8 MDL No. :MFCD00955770
Formula : C6H6N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :HZCWTTHQRMHIIE-UHFFFAOYSA-N
M.W : 154.12 Pubchem ID :345370
Synonyms :

Calculated chemistry of [ 21901-18-8 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 40.85
TPSA : 78.68 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.13 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.76
Log Po/w (XLOGP3) : 0.16
Log Po/w (WLOGP) : 0.59
Log Po/w (MLOGP) : -0.51
Log Po/w (SILICOS-IT) : -0.19
Consensus Log Po/w : 0.16

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.23
Solubility : 8.99 mg/ml ; 0.0583 mol/l
Class : Very soluble
Log S (Ali) : -1.37
Solubility : 6.58 mg/ml ; 0.0427 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.69
Solubility : 3.18 mg/ml ; 0.0207 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.94

Safety of [ 21901-18-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 21901-18-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 21901-18-8 ]
  • Downstream synthetic route of [ 21901-18-8 ]

[ 21901-18-8 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 21901-18-8 ]
  • [ 399-88-2 ]
Reference: [1] Journal of Organic Chemistry, 1955, vol. 20, p. 1729,1731
  • 2
  • [ 21901-18-8 ]
  • [ 3430-27-1 ]
Reference: [1] Journal of Organic Chemistry, 1955, vol. 20, p. 1729,1731
  • 3
  • [ 21901-18-8 ]
  • [ 5832-44-0 ]
Reference: [1] Journal of the American Chemical Society, 1954, vol. 76, p. 3167
  • 4
  • [ 695-34-1 ]
  • [ 21901-41-7 ]
  • [ 21901-18-8 ]
Reference: [1] Journal of Fluorine Chemistry, 2011, vol. 132, # 8, p. 541 - 547
  • 5
  • [ 6635-86-5 ]
  • [ 21901-18-8 ]
YieldReaction ConditionsOperation in experiment
97.6% at 0℃; Reflux Synthesis of the compound 9 The compound 8 (11 g, 0.072mol) was added into 150 mL of water, a concentrated sulphuric acid (11mL) was slowly added with agitation and cooled to 0°C in an ice bath. Sodium nitrite (9 g, 0.130 mol) was dissolved in 20mL of water and the solution was added slowly beneath the liquid surface of the reaction solution via a long stem funnel. The reaction was run at room temperature for 2 h and was boiled up until end of the reaction marked by no further emission of a brown gas was observed. Then the reaction solution was cooled, filtered, and dried to obtain 10.8 g of the compound 9 with a yield of 97.6percent. The melting point is 222.3-222.6°C (water)(being in consistent with that disclosed in reference), 231.6-231.8°C(ethanol).
Reference: [1] Patent: EP2366691, 2011, A1, . Location in patent: Page/Page column 7
[2] Journal of the American Chemical Society, 1950, vol. 72, p. 2806
[3] Journal of Organic Chemistry, 1955, vol. 20, p. 1729,1731
[4] Chemical and Pharmaceutical Bulletin, 2008, vol. 56, # 6, p. 775 - 780
[5] Chemical and Pharmaceutical Bulletin, 2017, vol. 65, # 1, p. 66 - 81
[6] Medicinal Chemistry, 2017, vol. 13, # 4, p. 365 - 374
  • 6
  • [ 695-34-1 ]
  • [ 21901-41-7 ]
  • [ 21901-18-8 ]
Reference: [1] Journal of Fluorine Chemistry, 2011, vol. 132, # 8, p. 541 - 547
  • 7
  • [ 695-34-1 ]
  • [ 21901-18-8 ]
Reference: [1] Patent: EP2366691, 2011, A1,
  • 8
  • [ 21901-18-8 ]
  • [ 23056-39-5 ]
YieldReaction ConditionsOperation in experiment
75.3% for 4 h; Reflux Synthesis of the compound 10 The compound 9 (13g, 0.084mol) was added into 50mL of phosphorus oxychloride, the mixture was heated under reflux for 4 h, and distilled to remove excessive phosphorus oxychloride. The resulted product was recrystallized in 50mL of ethanol (75percent) to yield 11 g of a white solid product with yield of 75.3percent. The melting point: 51.7-52.1 °C(ethanol) (M.P. 52.0-52.9 °C was reported in reference)[J.O.C., 1955, 20, 1729-1731].
Reference: [1] Beilstein Journal of Organic Chemistry, 2009, vol. 5,
[2] Patent: EP2366691, 2011, A1, . Location in patent: Page/Page column 7
[3] Journal of Organic Chemistry, 1955, vol. 20, p. 1729,1731
[4] Journal of the American Chemical Society, 1954, vol. 76, p. 3167
[5] Chemical and Pharmaceutical Bulletin, 2008, vol. 56, # 6, p. 775 - 780
[6] Chemical and Pharmaceutical Bulletin, 2017, vol. 65, # 1, p. 66 - 81
[7] Medicinal Chemistry, 2017, vol. 13, # 4, p. 365 - 374
  • 9
  • [ 21901-18-8 ]
  • [ 10026-13-8 ]
  • [ 23056-39-5 ]
Reference: [1] Patent: US5366972, 1994, A,
  • 10
  • [ 21901-18-8 ]
  • [ 59290-82-3 ]
Reference: [1] Journal of the American Chemical Society, 1954, vol. 76, p. 3167
  • 11
  • [ 21901-18-8 ]
  • [ 393-53-3 ]
Reference: [1] Journal of Organic Chemistry, 1955, vol. 20, p. 1729,1731
  • 12
  • [ 21901-18-8 ]
  • [ 133627-45-9 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2017, vol. 65, # 1, p. 66 - 81
[2] Medicinal Chemistry, 2017, vol. 13, # 4, p. 365 - 374
  • 13
  • [ 21901-18-8 ]
  • [ 76006-11-6 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2017, vol. 65, # 1, p. 66 - 81
[2] Medicinal Chemistry, 2017, vol. 13, # 4, p. 365 - 374
  • 14
  • [ 21901-18-8 ]
  • [ 353281-15-9 ]
Reference: [1] Patent: EP2366691, 2011, A1,
  • 15
  • [ 21901-18-8 ]
  • [ 228410-90-0 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2013, vol. 4, # 5, p. 460 - 465
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 21901-18-8 ]

Amides

Chemical Structure| 6332-56-5

[ 6332-56-5 ]

3-Nitropyridin-2(1H)-one

Similarity: 0.88

Chemical Structure| 228410-90-0

[ 228410-90-0 ]

5-bromo-2-hydroxy-3-nitro-4-picoline

Similarity: 0.84

Chemical Structure| 88511-57-3

[ 88511-57-3 ]

4-Amino-3-nitropyridin-2(1H)-one

Similarity: 0.82

Chemical Structure| 1446237-40-6

[ 1446237-40-6 ]

5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one

Similarity: 0.80

Chemical Structure| 33252-64-1

[ 33252-64-1 ]

3-Nitro-5-(trifluoromethyl)pyridin-2(1H)-one

Similarity: 0.78

Nitroes

Chemical Structure| 6332-56-5

[ 6332-56-5 ]

3-Nitropyridin-2(1H)-one

Similarity: 0.88

Chemical Structure| 228410-90-0

[ 228410-90-0 ]

5-bromo-2-hydroxy-3-nitro-4-picoline

Similarity: 0.84

Chemical Structure| 88511-57-3

[ 88511-57-3 ]

4-Amino-3-nitropyridin-2(1H)-one

Similarity: 0.82

Chemical Structure| 1446237-40-6

[ 1446237-40-6 ]

5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one

Similarity: 0.80

Chemical Structure| 33252-64-1

[ 33252-64-1 ]

3-Nitro-5-(trifluoromethyl)pyridin-2(1H)-one

Similarity: 0.78

Related Parent Nucleus of
[ 21901-18-8 ]

Pyridines

Chemical Structure| 6332-56-5

[ 6332-56-5 ]

3-Nitropyridin-2(1H)-one

Similarity: 0.88

Chemical Structure| 228410-90-0

[ 228410-90-0 ]

5-bromo-2-hydroxy-3-nitro-4-picoline

Similarity: 0.84

Chemical Structure| 88511-57-3

[ 88511-57-3 ]

4-Amino-3-nitropyridin-2(1H)-one

Similarity: 0.82

Chemical Structure| 1446237-40-6

[ 1446237-40-6 ]

5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one

Similarity: 0.80

Chemical Structure| 33252-64-1

[ 33252-64-1 ]

3-Nitro-5-(trifluoromethyl)pyridin-2(1H)-one

Similarity: 0.78